A glucose oxidase-peroxidasemethod for continuous automated monitoring of blood glucosehas been developed.The responseis linear over the range 0-800 mg/100 ml. Sensitivity can be maintained for 24 hr or longer and can be restored by rinsing the analytic system with sulfuric acid to permit studies of longer than 48 hr in duration. A precisionof ± 1% can be maintained between rinsesfor samplescontaining 100-600 mg of glucoseper 100 ml. This method is satisfactorily specific for glucose: The response with other sugars is less than 1% of the response obtained with the same concentration of glucose. Ascorbic acid causes no significant inhibition of the response to glucose. The inhibition by uric acid has been reduced fifty-fold compared to that in other methods. Transit through the sampling catheter and analytic system requires 15 mm. Timed from the first detectable response to a change in concentration, 25% of total responseis achieved in 30 sec and 90% in 80 sec. Fifty percent of an oscillation with a half-period of 45 sec can be detected; no oscillations this short were observedin records of human blood glucose. Applicability and feasibility of this method have been demonstrated in over 2000 hr of repeated blood glucose recordingsin 12 diabetic and 6 normal subjects. 
nyctohemeral cycles, especially in the most unstable (brittle) diabetics (1) . Our methods were designed so that data could be obtained regarding these rapid changes in blood glucose while an experiment was in progress for periods of 48 hr. For the determination of blood glucose, we selected a continuous monitoring technic in which the patient was attached directly to the analytic equipment by a catheter long enough to permit freedom of movement.
An automate(l method for continuous determination of blood sugar in hulnall subjects was first described by Weller et al (2) For a given range, the precision for low glucose concentrations is limited by the minimal transmittance change which can be read from the stri1) record. Since the determination depends on the disappearance, rather than tile appearance, of color, equal increments of glucose result in progressively smaller increments of transmittance as the glucose concentration of tile analyzed sample decreases.
The precision improves as the range of the method is decreased.
Readability errors equivalent to ±0.2% transmittance or greater appear likely from the published data for all ranges (2) (3) (4) (5) (6) (7) (8) .
For a range of 0-500 mg/100 ml, the error equivalent to ±0.2% transmittance would be ±5% of the true value at 50 mg/100 ml, ±2% at 100, ±1%, at 200, and ±3% at 500 mg/100 ml. For a range of 0-250 mg/ 100 ml (40-100% transmittance), the error equivalent to ±0.2% transmittallce would be at least ±2% at 50 mg/100 ml and ±1% at 100 mg/ 100 ml. (Reducing the readabilityerror to ±0.1% transmittance would reduce the equivalent error to one half of that for ±0.2% transmittance. ) Furthermore, the ferricyanide method is not specific for glucose.
Nonglucose reducing substances of plasma contribute a small but variable increment to the reading on the strip record.
As the ferricyanide method is used in tile routine clinical laboratory, its limitations either are minimized by restricting the range of the samples (usually to 50-250 mg/lOt) ml) and standardizing frequently or are considered unimportant for a routine chemical determination. 
Materials and Methods

Analytic System
The analyzing system consists of AutoAnalyzer* modules and suitable containers for reagents and waste solutions, all mounted on a mobile cart (Fig 1) for convenient use in a hospital room. The components of the analyzing system and flow scheme are diagrammed in Fig 2 and 3 . The blood is pumped directly from the patient, by means of a Teflon catheter (internal diameter, 0.015 in.),at a rate of 0.1 mi/mm, successively through two proportioning pumps.
The analytic system has too many lines for one pump (Technicon proportioning pump I) to handle with consistent, noise-free performance. Furthermore, the use of two pumps has a safety feature in that if the roller chain of one is accidentally released, the other will prevent flow of reagents into the subject. This is a possibility in systems with only one pump because occasional obstructions have been observed in the reagent lines and could result in a higher pressure in the analytic system than in the sampling catlleter in the subject.In addition,the long sampling catheter The mean relative standard deviation from the response predicted by Beer's law was less than ±1%, as determined from linear regression lines based on minimizing the sums of squares of fractional (relative)absorbance deviations.The nine samples were made up by gravimetric methods to 50, 100, 200, 300, 400, 500, 600, 700, and 800 mg/100 ml with 0.2% benzoic acid in double-deionized water as a diluent.
Each solution was aged at least 1 month at room temperature before being used. The mean deviation of the blanks of the 21 calibrations from the extrapolated values was 0.006 absorbance units.
Range
The usable range of the present method is 0-800 mg/100 ml. The upper limit gives an absorbance of about 1.2. Above this value, the effective sensitivity error increases rapidly owing to the limitation in reading the strip record and, in addition, the response becomes somewhat unpredictable. Blood glucose values beyond this range have not been encountered even in the most severely diabetic patients in our studies to the present.
To achieve a linear response to 800 mg of glucose per 100 ml, an o-dianisidine concentration of 800 mg/liter in the enzyme- With the use of Tris*ma1eate buffer (pH 7.0),we observed precipitation of dye in the stored enzyme-dye solution, which resulted in a loss of sensitivityabove 400 mg/100 ml and, consequently, a lossof linearity. Since substitutingcitricacidlbuffer (pH 5.0),in which tileo-dianisidine dye is more soluble, we have not encountered this problem.
In fact, the enzyme-dye-citric acid buffer preparation gives linear results up to 800 mg/100 ml, even after storage at 4#{176} for as long as 10 days. abruptly from 500 to 0 mg/100 ml. Time is measured from first detectable response to new concentration; percent lack of attainment of steady state refers to the change from complete response at high level to complete response at low (0 mg/lOG ml) level.
Sensitivity
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ROSEVEAR ET AL Clinical Chemistr) solution with Triton X-100 at a concentration of 10 ml/liter (Fig 5) . However, slight loss of sensitivity (7%) occurs at 10 ml/liter as compared to 5 mi/liter.
One effect of the higher concentration of Triton X-100 is decreased trailingof the oxidized dye (Fig 6) . The higher effective sensitivity and range of the present method were necessary for a system which was to be used for monitoring the unusually high and low levels of blood glucose that we have observed in ulistable diabetics (Fig 9) .
Specificity
The response of the analytic system is less than 1% of its response to glucose when tested at 100 mg/100 ml with the following sugars: D-galactose, D-fructose, n-mannose, n-ribose, D-xylose, L-xyloSe, sucrose, and lactose.
With maltose the response is 1.3%. The only known exception to the specificity of glucose oxidase for D-glUcoSe is 2-deoxyn-glucose. This is not a usual constituent of plasma and even if present gives a response of only 12% of that for rI-glucose (21, 22).
The effectof uric acid was tested on solutions of glucose (100 mg/ 100 ml) in 0.1 M pH 8.0 Tris and sodium phosphate buffers. The response to glucose in the same solution but without uric acid was used as a control.
No effect could be detected with uric acid concentrations of 0.5 and 5 mg/100 ml. At 50 mg/100 ml, 10 times the normal value for serum, there was 1.2 and 0.7% inhibition in the Tris and I)hoSPhate buffers, respectively. This inhibition is equivalent to only 0.02% for each 1 mg of uric acid per 100 ml of solution.
Other investigators Consequently, the glucose solutions used for standardizing the present method were allowed to stand at least 24 hr at room temperature before they were analyzed to ensure that they contailled an equilibrium mixture of the and $ forms comparable to that of plasma.
Stability
The stabilityof the analytic system can be illustratedby data from a typical continuous monitoring which ran for 24 hr. 
Dynamic Response
The delay time from a change in blood glucose level in the subject to the first detectable change in the recording apparatus is 15 mm. It takes 5 mm for blood to traverse 10 ft of Teflon catheter and 10 mm for transit through the analytic equipment. there is a similar delay in the attainment of the final3-5% of the steady state (Fig 7) . into the stream of blood being aspirated by way of the intravascularly placed catheter (f, 6, 12). We, as well as others (3), have noted interruptions in blood flow due to clot formation in the catheter tip when blood is heparinized extraeorporeally in this manner. Another problem encountered has been the variable and unpredictable dilution of the aspirated blood with the heparin solution (6, 12). Both problems were avoided by administering the heparin to the patient.
Nonetheless, we recognize that for some studies the problems associated with the effects of heparin may exceed those associated with occasional clot formation and loss of precision due to extracorporeal heparinization. 
ROSEVEAR ET AL
